We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
-0.97%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$5.44B
AUM Growth
-$517M
Cap. Flow
-$1.1B
Cap. Flow %
-20.26%
Top 10 Hldgs %
16.51%
Holding
1,406
New
141
Increased
183
Reduced
106
Closed
202

Top Buys

Rank Stock Value
1
AXP icon
American Express
AXP
+$60M
2
ALL icon
Allstate
ALL
+$46.9M
3
WFC icon
Wells Fargo
WFC
+$45.7M
4
NI icon
NiSource
NI
+$41.1M
5
BNY
Bank of New York Mellon
BNY
+$41M

Sector Composition

Rank Sector Weight
1 Technology 13.28%
2 Financials 12.39%
3 Healthcare 3.91%
4 Consumer Discretionary 3.9%
5 Communication Services 3.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FUV
1126
DELISTED
Arcimoto, Inc. Common Stock
FUV
$14K ﹤0.01%
511
ONCT
1127
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$14K ﹤0.01%
789
AWH
1128
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$13K ﹤0.01%
2,305
SURF
1129
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$13K ﹤0.01%
12,608
REKR icon
1130
Rekor Systems
REKR
$83.8M
$12K ﹤0.01%
12,063
UAVS icon
1131
AgEagle Aerial Systems
UAVS
$41.4M
$12K ﹤0.01%
25
VATE icon
1132
INNOVATE Corp
VATE
$114M
$12K ﹤0.01%
1,689
TECX
1133
Tectonic Therapeutic
TECX
$573M
$12K ﹤0.01%
1,502
TRVN
1134
DELISTED
Trevena, Inc.
TRVN
$12K ﹤0.01%
124
GBRGR
1135
DELISTED
Goldenbridge Acquisition Limited Right
GBRGR
$11K ﹤0.01%
75,000
ATNX
1136
DELISTED
Athenex, Inc. Common Stock
ATNX
$11K ﹤0.01%
2,056
EAR
1137
DELISTED
Eargo, Inc. Common Stock
EAR
$11K ﹤0.01%
537
SYRE icon
1138
Spyre Therapeutics
SYRE
$8.87B
$10K ﹤0.01%
769
MTEM
1139
DELISTED
Molecular Templates, Inc.
MTEM
$10K ﹤0.01%
879
RUBY
1140
DELISTED
Rubius Therapeutics, Inc
RUBY
$9K ﹤0.01%
21,844
IVC
1141
DELISTED
Invacare Corporation
IVC
$9K ﹤0.01%
12,005
NGNE icon
1142
Neurogene
NGNE
$696M
$8K ﹤0.01%
628
SFT
1143
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
$7K ﹤0.01%
1,070
BTWNW
1144
DELISTED
Bridgetown Holdings Limited Warrants
BTWNW
$6K ﹤0.01%
50,000
LOTZ
1145
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
$4K ﹤0.01%
12,767
AMPE
1146
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$4K ﹤0.01%
232
HGEN
1147
DELISTED
HUMANIGEN, INC.
HGEN
$3K ﹤0.01%
+17,406
New +$9.37K
NH
1148
DELISTED
NantHealth, Inc
NH
$3K ﹤0.01%
853
SDSTW
1149
Stardust Power Inc Warrant
SDSTW
$4.56M
$2K ﹤0.01%
29,166
CCV.WS
1150
DELISTED
Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCV.WS
$2K ﹤0.01%
25,000

Similar funds

LMR Partners's Q3 2022 Portfolio in Review

As of Q3 2022, LMR Partners held 1,406 positions worth $5.44B, down 8.7% from $5.96B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

LMR Partners withdrew a net $1.1B in Q3 2022, closing 202 positions and reducing 106 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $264M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.

Against the trend, LMR Partners opened a new position in Allstate worth $47M.

  • LMR Partners's largest Q3 2022 buy was Allstate: 377,327 shares worth $47M.
  • LMR Partners added most to American Express in Q3 2022, an estimated $60M increase.
  • LMR Partners's biggest Q3 2022 reduction was TSMC, cutting an estimated $179M.
  • LMR Partners fully exited State Street SPDR S&P 500 ETF Trust in Q3 2022, selling an estimated $264M.
  • LMR Partners's ten largest holdings make up 17% of its $5.44B portfolio in Q3 2022.
  • LMR Partners opened 141 new positions and closed 202 in Q3 2022.
  • LMR Partners's portfolio value fell 8.7% quarter-over-quarter to $5.44B.

Based on LMR Partners's 13F filing for Q3 2022, filed 14 Nov 2022.